Agios Pharmaceuticals, Inc. (AGIO)
31.80
-0.68
(-2.09%)
USD |
NASDAQ |
Oct 02, 16:00
31.82
+0.02
(+0.06%)
After-Hours: 20:00
Agios Pharmaceuticals Profit Margin (Quarterly) : -225.1% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -225.1% |
| March 31, 2026 | -477.7% |
| December 31, 2025 | -541.1% |
| September 30, 2025 | -803.1% |
| June 30, 2025 | -899.4% |
| March 31, 2025 | -1.02K% |
| December 31, 2024 | -899.6% |
| September 30, 2024 | |
| June 30, 2024 | -1.12K% |
| March 31, 2024 | -995.8% |
| December 31, 2023 | -1.35K% |
| September 30, 2023 | -1.23K% |
| June 30, 2023 | -1.25K% |
| March 31, 2023 | -1.44K% |
| December 31, 2022 | |
| September 30, 2022 | -2.32K% |
| June 30, 2022 | -1.64K% |
| March 31, 2022 | -11.39K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | -288.8% |
| September 30, 2019 | -408.0% |
| June 30, 2019 | -419.0% |
| March 31, 2019 | -307.9% |
| December 31, 2018 | -305.8% |
| September 30, 2018 | -622.9% |
| June 30, 2018 | -170.1% |
| March 31, 2018 | -1.04K% |
| December 31, 2017 | -901.0% |
| September 30, 2017 | -679.1% |
| June 30, 2017 | -732.3% |
| March 31, 2017 | -629.7% |
| December 31, 2016 | -249.4% |
| September 30, 2016 | -699.3% |
| June 30, 2016 | -801.8% |
| March 31, 2016 | -74.16% |
| December 31, 2015 | -653.3% |
| September 30, 2015 | -734.6% |
| June 30, 2015 | -241.3% |
| March 31, 2015 | -14.49% |
| December 31, 2014 | -182.2% |
| September 30, 2014 | 10.93% |
| June 30, 2014 | -217.5% |
| March 31, 2014 | -145.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Biogen, Inc. | 3.72% |
| Insmed, Inc. | -3.11% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Regeneron Pharmaceuticals, Inc. | 30.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.38% |
| Return on Assets | -31.89% |
| Return on Invested Capital | -33.26% |
| Gross Profit Margin (Quarterly) | 90.29% |
| Operating Margin (Quarterly) | -247.1% |
| Return on Net Operating Assets | -486.9% |